drugset / Trial / NCT00888329
Aprepitant for Prevention of Postoperative Nausea and Vomiting in Elective Hysterectomy
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of the study is to determine whether 40 mg aprepitant administered before surgery is effective for preventing vomiting in the first 24 hours after surgery in women undergoing elective hysterectomy.
Timeline
- Start
- 2007-07
- Primary completion
- 2011-10
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aprepitant | Other / unclassified | 40 mg | Oral |
Indications
No indication recorded.